+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America, Europe & Asia Pacific Legal Cannabis Market Size, Share & Trends Analysis Report by Source Type, by Derivatives, by End-use, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • June 2022
  • Region: Asia Pacific, Europe, North America
  • Grand View Research
  • ID: 5626300
Description Jump to:
The North America, Europe, and Asia Pacific legal cannabis market size is expected to reach USD 89.9 billion by 2030. It is expected to expand at a CAGR of 25.3% from 2022 to 2030. As more individuals become aware of the medical benefits of hemp, marijuana, and its derivatives, and as these products become more generally available, acceptance is expanding. Another key factor boosting market expansion is the increased acceptance of medicinal marijuana for the treatment of chronic diseases. Legalizing marijuana for adult use in many countries will assist in creating new job possibilities and add significantly to the economy. Tourism, real estate, finance, food, and transportation are just a few of the industries that will benefit from legalization. Manufacturers are facing challenges in setting up a functional and legalized channel for the development and trade of cannabis-derived products like cannabidiol due to the presence of strict laws.



The marijuana product segment led the market with a revenue share of over 70.0% in 2021. Marijuana for medical purposes is increasing in popularity as a result of recent legalizations in a number of nations. Patients with chronic diseases like Parkinson's disease, cancer, arthritis, Alzheimer's disease, and neurologic issues like depression, anxiety, and epilepsy are treated with marijuana. As a result, one of the primary reasons behind the expansion of this market is the widespread use of marijuana for the treatment of numerous chronic illnesses.

The CBD derivatives segment accounted for the largest revenue share in 2021 owing to the vast applications of these derivatives. It is extensively being used for medicinal purposes as well as for the cosmetic industry. In the APAC region, the cosmetic industry is a huge business and there has been a surge in the use of CBD derivatives in various skincare products. The others segment, being the fastest-growing category, is seeing an upward trend due to the increasing number of studies proving their prowess in the medical field.

The medical use segment emerged as the largest end-use segment in 2021. As medical cannabis is allowed in more countries than adult-use cannabis, the medical sector is likely to stay dominant during the forecast period. The increasing usage of cannabis and its derivatives in a variety of applications, including medicines, nutraceuticals, personal care and cosmetics, and edibles, is expected to increase the demand for these goods.

With a revenue share of over 80.0% in 2021, North America led the market. The availability of a large customer pool in the region and the early legalization of marijuana for medical and recreational use are major factors driving the market. Asia Pacific is predicted to be the fastest-growing market from 2022 to 2030 owing to the increased understanding of cannabis' medical and health benefits, which has prompted Asian countries to legalize cannabis and its derivatives.

During the pandemic, lockdowns and transit disruptions produced a disturbance in product supply, increasing the supply-demand disparity. As a result, the localized market and the worldwide market have been hampered. As customers gravitate away from traditional treatment approaches and move toward cannabis-based treatment, increased use of marijuana, largely for medicinal purposes, boosts the total market growth. Furthermore, the COVID-19 pandemic has significantly impacted the legal cannabis industry as a statewide lockdown has interrupted product production and imposed import/export restrictions, resulting in lower total revenue.

North America, Europe & Asia Pacific Legal Cannabis Market Report Highlights

  • The market growth can be attributed to the greater use of hemp and marijuana products and increasing preference for medical marijuana. In addition, the upcoming legalization of marijuana for adult use is expected to boost growth over the predicted period.
  • Due to the increased acceptance of marijuana for various medical illnesses, marijuana emerged as the leading source type in 2021.
  • By end-use, the medical use segment held the largest revenue share in 2021. This is due to an increase in the product's use for chronic pain, mental illnesses such as anxiety, and sleep difficulties and increased knowledge among practitioners.
  • Owing to the increasing consumption rate as a result of legalization, North America accounted for the largest revenue share in 2021.

Table of Contents

Chapter 1 Executive Summary
1.1 Market Summary
Chapter 2 North America, Europe & Asia Pacific Legal Cannabis Market: Variables, Trends & Scope
2.1 Estimated Number of Cannabis Users from 2017 to 2030, by Country
2.1.1 Estimated Number of Medical Marijuana Users from 2017 to 2030, by Country
2.2 Legal Cannabis Regulatory Scenario, By Country
2.2.1 Australia
2.2.1.1 Overview
2.2.1.2 Cultivation
2.2.1.3 Manufacturing
2.2.1.4 Regulatory Bodies Involved
2.2.2 U.S.
2.2.2.1 Overview
2.2.2.2 Cultivation
2.2.2.3 Regulatory Bodies Involved
2.2.3 Canada
2.2.3.1 Overview
2.2.3.2 Cultivation
2.2.3.3 Production
2.2.3.4 Regulatory Bodies Involved
2.2.4 Germany
2.2.4.1 Overview
2.2.4.2 Cultivation/Production
2.2.4.3 Regulatory Bodies Involved
2.2.5 Italy
2.2.5.1 Overview
2.2.5.2 Cultivation
2.2.5.3 Regulatory Bodies Involved
2.2.6 Netherlands
2.2.6.1 Overview
2.2.6.2 Cultivation
2.2.6.3 Regulatory Bodies Involved
2.2.7 Czech Republic
2.2.7.1 Overview
2.2.7.2 Cultivation/Production
2.2.7.3 Regulatory Bodies Involved
2.2.8 Poland
2.2.8.1 Overview
2.2.8.2 Cultivation/Production
2.2.8.3 Regulatory Bodies Involved
2.2.9 Switzerland
2.2.9.1 Overview
2.2.9.2 Cultivation/Production
2.2.9.3 Regulatory Bodies Involved
2.2.10 New Zealand
2.2.10.1 Overview
2.2.10.2 Cultivation/Production
2.2.10.3 Regulatory Bodies Involved
2.2.11 Thailand
2.2.11.1 Overview
2.2.11.2 Cultivation/Production
2.2.11.3 Regulatory Bodies Involved
2.2.12 Japan
2.2.12.1 Overview
2.2.12.2 Cultivation/Production
2.2.12.3 Regulatory Bodies Involved
2.2.13 South Korea
2.2.13.1 Overview
2.2.13.2 Cultivation/Production
2.2.13.3 Regulatory Bodies Involved
2.3 Market Dynamics
2.3.1 Market Driver Analysis
2.3.1.1 Growing legalization of medical marijuana in various countries
2.3.1.2 Growing adoption of medical marijuana for the treatment of chronic diseases
2.3.1.3 Increasing demand for cannabis driving cannabis cultivation across the globe
2.3.1.4 Elimination of the black market through the legalization of medical marijuana
2.3.1.5 Impending legalization of marijuana for recreational/adult use
2.3.1.6 Increasing need for potent cannabis and recent technological advancements
2.3.1.7 Increasing preference toward cannabis extracts such as oils and tinctures
2.3.1.8 Growing legalization of cannabis-based CBD products
2.3.1.9 Growing adoption of CBD-based products for treating various medical conditions
2.3.1.10 Rise in the number of retailers selling CBD-based products
2.3.2 Market Restraint Analysis
2.3.2.1 Absence of legalization programs in several Asian and African countries
2.3.2.2 Strict government regulations
2.3.2.3 Legalization of medical cannabis only for selected indications
2.3.2.4 High pricing of medical cannabis
2.3.2.5 High pricing of cannabis compared to illegal markets in the U.S.
2.3.2.6 Illicit cannabis trade
2.3.3 Industry Challenges
2.3.3.1 Incomplete evidence regarding the effectiveness of medical marijuana
2.3.3.2 Reluctance of doctors to prescribe cannabis
2.3.3.3 Lower market access to cannabis due to the absence of legalization programs, leading to smuggling
2.4 Industry Analysis -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
2.4.1 Political and Legal Landscape
2.4.2 Economic and Social Landscape
2.4.3 Technology Landscape
2.5 Cannabinoid Summary
2.5.1 Cannabidiol (CBD)
2.5.2 Tetrahydrocannabinol (THC)
2.5.3 Cannbinol (CBN)
2.5.4 CBG
2.5.5 Terpenes
2.5.6 Flavonoids
2.5.7 cannabinoid Acids
2.5.8 Entourage Effect
2.6 Analysis on Mode of Ingestion
2.7 Cannabis Pricing Analysis, By Country, 2020-2030 (USD)
2.8 COVID-19 Impact on the market
Chapter 3 Legal Cannabis Market: Source Type Estimates & Trend Analysis
3.1 Market Definition
3.2 Legal Cannabis Market: Source Type Movement Analysis
3.3 Legal Cannabis Market: Source Type Analysis
3.3.1 Hemp
3.3.1.1 Hemp Market Estimates and Forecasts, 2017-2030 (USD Million)
3.3.1.2 Hemp CBD
3.3.1.3 Supplements
3.3.1.4 Industrial Hemp
3.3.2 Marijuana
3.3.2.1 Marijuana Market Estimates and Forecasts, 2017-2030 (USD Million)
3.3.2.2 Flower
3.3.2.3 Oil & Tincture
Chapter 4 North America, Europe & Asia Pacific Legal Cannabis Market: End-use Estimates & Trend Analysis
4.1 Legal Cannabis Market: End-use Movement Analysis
4.2 Legal Cannabis Market: End-use Analysis
4.2.1 Medical Use
4.2.1.1 Medical Use Market Estimates and Forecasts, 2017-2030 (USD Million)
4.2.1.2 Cancer
4.2.1.3 Chronic Pain
4.2.1.4 Depression and Anxiety
4.2.1.5 Arthritis
4.2.1.6 Diabetes
4.2.1.7 Glaucoma
4.2.1.8 Migraines
4.2.1.9 Epilepsy
4.2.1.10 Multiple Sclerosis
4.2.1.11 AIDS
4.2.1.12 Amyotrophic Lateral Sclerosis
4.2.1.13 Alzheimer’s
4.2.1.14 Post-Traumatic Stress Disorder (PTSD)
4.2.1.15 Parkinson's
4.2.1.16 Tourette’s
4.2.1.17 Others
4.2.2 Industrial Use
4.2.2.1 Industrial Use Market Estimates and Forecasts, 2017-2030 (USD Million)
4.2.3 Recreational Use
4.2.3.1 Recreational use Market Estimates and Forecasts, 2017-2030 (USD Million)
Chapter 5 Legal Cannabis Market: Derivatives Estimates & Trend Analysis
5.1 Market Definition
5.2 Legal Cannabis Market: Derivatives Movement Analysis
5.3 Legal Cannabis Market: Derivatives Analysis
5.3.1 CBD
5.3.1.1 CBD Market Estimates and Forecasts, 2017-2030 (USD Million)
5.3.2 THC
5.3.2.1 THC Market Estimates and Forecasts, 2017-2030 (USD Million)
5.3.3 Others
5.3.3.1 Others Market Estimates and Forecasts, 2017-2030 (USD Million)
Chapter 6 North America, Europe & Asia Pacific Legal Cannabis Market: Regional Estimates & Trend Analysis
6.1 Legal Cannabis Market: Country Analysis, 2021 & 2030
6.1.1 U.S.
6.1.1.1 U.S. Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.2 Canada
6.1.2.1 Canada Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.3 Germany
6.1.3.1 Germany Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.4 Italy
6.1.4.1 Italy Legal Cannabis Market Estimates And Forecasts, 2017-2030 (USD Million)
6.1.5 Poland
6.1.5.1 Poland Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.6 Czech Republic
6.1.6.1 Czech Republic Legal Cannabis Market Estimates And Forecasts, 2017-2030 (USD Million)
6.1.7 Switzerland
6.1.7.1 Switzerland Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.8 Netherlands
6.1.8.1 Netherlands Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.9 Australia
6.1.9.1 Australia Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.10 New Zealand
6.1.10.1 New Zealand Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.11 Japan
6.1.11.1 Japan Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.12 South Korea
6.1.12.1 South Korea Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.1.13 Thailand
6.1.13.1 Thailand Legal Cannabis Market Estimates and Forecasts, 2017-2030 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company Profiles: International Players
7.1.1 CANOPY GROWTH CORPORATION
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Strategic initiatives
7.1.2 Aurora Cannabis
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Strategic initiatives
7.1.3 Tilray
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Strategic initiatives
7.1.4 GW Pharmaceuticals, plc.
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Strategic initiatives
7.1.5 Organigram Holdings Inc.
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Strategic initiatives
7.1.6 Lexaria Bioscience Corp.
7.1.6.1 Company overview
7.1.6.2 Financial performance
7.1.6.3 Strategic initiatives
7.1.7 VIVO Cannabis Inc.
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Strategic Initiatives
7.1.8 The Cronos Group
7.1.8.1 Company overview
7.1.8.2 Financial performance
7.1.8.3 Strategic Initiatives
7.2 Company Profiles: ASX Listed Cannabis Companies
7.2.1 AusCann Group Holdings Ltd.
7.2.1.1 Company overview
7.2.1.2 Strategic initiatives
7.2.2 Cann Group Limited
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Strategic initiatives
7.2.3 Bod Australia
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Strategic Initiatives
7.2.4 Zelira Therapeutics
7.2.4.1 Company Overview
7.2.4.2 Strategic Initiatives
7.2.5 Althea Group
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Strategic Initiatives
7.2.6 THC Global Group Limited
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Strategic Initiatives
7.2.7 MGC Pharma
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Strategic Initiatives
7.2.8 ECOFIBRE
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Strategic Initiatives
Chapter 8 Methodology and Scope
8.1 Research Methodology
8.1.1 Information procurement
8.2 Information or Data Analysis
8.3 Market Formulation & Validation
8.3.1 Region Market: CAGR Calculation
8.4 Region-Based Segment Share Calculation
8.5 List of Secondary Sources
8.6 List of Primary Sources
List of Tables
Table 1 Cannabis user pool analysis, by country, 2017-2030 (in thousands)
Table 2 Medical marijuana users pool analysis, by country, 2017-2030
Table 3 Average price of marijuana per mg, by country, 2021-2030 (USD)
Table 4 Average price of hemp CBD per mg, by country, 2021-2030 (USD)
Table 5 Opioid users pool analysis, by country, 2017-2030 (in thousands)
Table 6 Chronic pain patients, by country, 2017-2030 (in thousands)
Table 7 Inflammation patients, by country, 2017-2030 (in thousands)
Table 8 Anxiety patients, by country, 2021-2030 (in thousands)
Table 9 North America legal cannabis market, by source type, 2017-2030 (USD Million)
Table 10 North America legal cannabis market, by derivatives, 2017-2030 (USD Million)
Table 11 North America legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 12 U.S. legal cannabis market, by source type, 2017-2030 (USD Million)
Table 13 U.S. legal cannabis market, by derivatives, 2017-2030 (USD Million)
Table 14 U.S. legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 15 Canada legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 16 Canada legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 17 Canada legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 18 Europe legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 19 Europe legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 20 Europe legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 21 Germany legal cannabis market, by source type, 2017-2030 (USD Million)
Table 22 Germany legal cannabis market, by derivatives, 2017-2030 (USD Million)
Table 23 Germany legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 24 Italy legal cannabis market, by source type, 2017-2030 (USD Million)
Table 25 Italy legal cannabis market, by derivatives, 2017-2030 (USD Million)
Table 26 Italy legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 27 Netherlands legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 28 Netherlands legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 29 Netherlands legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 30 Poland legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 31 Poland legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 32 Poland legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 33 Czech Republic legal cannabis market, by source type, 2017-2030 (USD Million)
Table 34 Czech Republic legal cannabis market, by derivatives, 2017-2030 (USD Million)
Table 35 Czech Republic legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 36 Switzerland legal cannabis market, by source type, 2017-2030 (USD Million)
Table 37 Switzerland legal cannabis market, by derivatives, 2017-2030 (USD Million)
Table 38 Switzerland legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 39 APAC legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 40 APAC legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 41 APAC legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 42 Australia legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 43 Australia legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 44 Australia legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 45 New Zealand legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 46 New Zealand legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 47 New Zealand legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 48 Thailand legal cannabis market, by source type, 2017-2030 (USD Million)
Table 49 Thailand legal cannabis market, by derivatives, 2017-2030 (USD Million)
Table 50 Thailand legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 51 Japan legal cannabis market, by source type, 2017-2030 (USD Million)
Table 52 Japan legal cannabis market, by derivatives, 2017-2030 (USD Million)
Table 53 Japan legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 54 South Korea legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 55 South Korea legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 56 South Korea legal cannabis market, by end-use, 2017-2030 (USD Million)
Table 57 Partial list of secondary sources
Table 58 Partial list of primary sources
List of Figures
Fig. 1 Various stages of the research workflow
Fig. 2 Information procurement
Fig. 3 Market Formulation & Validation
Fig. 4 Number of clinical trials, by region
Fig. 5 Number of clinical trials, by medical conditions
Fig. 6 State-wise legalization scenario in the U.S.
Fig. 7 Country-wise legalization scenario in Europe
Fig. 8 Consumption of cannabis oil for oral use
Fig. 9 Percentage of respondents using cannabis edible products and those using products other than edibles
Fig. 10 Cannabis consumers (15 to 64 years) (2019)
Fig. 11 Cannabis users in Asian countries (Millions) (2019)
Fig. 12 Global legal marijuana trade route
Fig. 13 Global hemp trade route
Fig. 14 Supply Chain Network of Hemp Biomass to Industrial applications
Fig. 15 Supply chain network of the marijuana plant to marijuana oil
Fig. 16 Global legal cannabis market, source type outlook key takeaways (USD Million)
Fig. 17 Global legal cannabis market: source type movement analysis, 2020 & 2030 (USD Million)
Fig. 18 Marijuana market estimates and forecasts, 2017-2030 (USD Million)
Fig. 19 Flower market estimates and forecasts, 2017-2030 (USD Million)
Fig. 20 Oil and tinctures market estimates and forecasts, 2017-2030 (USD Million)
Fig. 21 Hemp market estimates and forecasts, 2017-2030 (USD Million)
Fig. 22 Hemp CBD market estimates and forecasts, 2017-2030 (USD Million)
Fig. 23 Supplements market estimates and forecasts, 2017-2030 (USD Million)
Fig. 24 Industrial Hemp market estimates and forecasts, 2017-2030 (USD Million)
Fig. 25 North America, Europe, and Asia Pacific legal cannabis market, derivatives outlook key takeaways (USD Million)
Fig. 26 North America, Europe, and Asia Pacific legal cannabis market: derivatives movement analysis, 2020 & 2030 (USD Million)
Fig. 27 CBD market estimates and forecasts, 2017-2030 (USD Million)
Fig. 28 THC market estimates and forecasts, 2017-2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2017-2030 (USD Million)
Fig. 30 North America, Europe, and Asia Pacific legal cannabis market, end-use outlook key takeaways (USD Million)
Fig. 31 North America, Europe, and Asia Pacific legal cannabis market: end-use movement analysis, 2021 & 2030 (USD Million)
Fig. 32 North America, Europe, and Asia Pacific legal cannabis market: proportion of hemp and marijuana by end-use (%)
Fig. 33 Medical use market estimates and forecasts, 2017-2030 (USD Million)
Fig. 34 Cancer market estimates and forecasts, 2017-2030 (USD Million)
Fig. 35 Chronic pain market estimates and forecasts, 2017-2030 (USD Million)
Fig. 36 Depression and anxiety market estimates and forecasts, 2017-2030 (USD Million)
Fig. 37 Arthritis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 38 Diabetes market estimates and forecasts, 2017-2030 (USD Million)
Fig. 39 Glaucoma market estimates and forecasts, 2017-2030 (USD Million)
Fig. 40 Migraines market estimates and forecasts, 2017-2030 (USD Million)
Fig. 41 Epilepsy market estimates and forecasts, 2017-2030 (USD Million)
Fig. 42 Multiple Sclerosis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 43 AIDS market estimates and forecasts, 2017-2030 (USD Million)
Fig. 44 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 45 Alzheimer's market estimates and forecasts, 2017-2030 (USD Million)
Fig. 46 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2017-2030 (USD Million)
Fig. 47 Parkinson's market estimates and forecasts, 2017-2030 (USD Million)
Fig. 48 Tourette’s market estimates and forecasts, 2017-2030 (USD Million)
Fig. 49 Others market estimates and forecasts, 2017-2030 (USD Million)
Fig. 50 Recreational use market estimates and forecasts, 2017-2030 (USD Million)
Fig. 51 Industrial use market estimates and forecasts, 2017-2030 (USD Million)
Fig. 52 North America, Europe, and Asia Pacific legal cannabis market, regional outlook key takeaways (USD Million)
Fig. 53 North America, Europe, and Asia Pacific legal cannabis market: regional movement analysis, 2020 & 2030 (USD Million)
Fig. 54 North America, Europe, and Asia Pacific legal cannabis market, by revenue and YOY growth
Fig. 55 North America legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 56 U.S. legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 57 Canada legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 58 Europe legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 59 Germany legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 60 Italy legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 61 Poland legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 62 Czech Republic legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 63 Switzerland legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 64 Netherlands legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 65 Asia Pacific legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 66 Thailand legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 67 Japan legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 68 South Korea legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 69 Australia legal cannabis market estimates and forecasts, 2017-2030 (USD Million)
Fig. 70 New Zealand legal cannabis market estimates and forecasts, 2017-2030 (USD Million)

Companies Mentioned

  • CANOPY GROWTH CORPORATION
  • Aurora Cannabis
  • Tilray
  • GW Pharmaceuticals, plc.
  • Organigram Holdings Inc.
  • Lexaria Bioscience Corp.
  • VIVO Cannabis Inc.
  • The Cronos Group
  • ASX Listed Cannabis Companies
  • Cann Group Limited
  • Bod Australia
  • Zelira Therapeutics
  • Althea Group
  • THC Global Group Limited
  • MGC Pharma
  • ECOFIBRE

Methodology

Loading
LOADING...

Related Topics

Related Reports

North America Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End Use (Medical, Recreational, Industrial), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

North America Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End Use (Medical, Recreational, Industrial), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • North America
From
Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report by Brand Type (Sativex, Epidiolex, Other Brands), Region (North America, Middle East and Africa, Asia-Pacific, Europe), and Segment Forecasts, 2024-2030 - Product Image

Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report by Brand Type (Sativex, Epidiolex, Other Brands), Region (North America, Middle East and Africa, Asia-Pacific, Europe), and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Legal Cannabis Market by Product, Application - Global Forecast 2025-2030 - Product Image

Legal Cannabis Market by Product, Application - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Cannabis Extract Market by Product, Source, Type - Global Forecast 2025-2030 - Product Image

Cannabis Extract Market by Product, Source, Type - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
North America Cannabis Market (2023 Edition): Analysis By Users and Penetration, Derivatives (CBD, THC, Others), Source (Marijuana, Hemp), End Use, By Country: Market Insights and Forecast (2019-2029) - Product Image

North America Cannabis Market (2023 Edition): Analysis By Users and Penetration, Derivatives (CBD, THC, Others), Source (Marijuana, Hemp), End Use, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • 150 Pages
  • North America
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.